ATE132755T1 - Mycobacterium vaccae in der behandlung von uveitis - Google Patents

Mycobacterium vaccae in der behandlung von uveitis

Info

Publication number
ATE132755T1
ATE132755T1 AT91919487T AT91919487T ATE132755T1 AT E132755 T1 ATE132755 T1 AT E132755T1 AT 91919487 T AT91919487 T AT 91919487T AT 91919487 T AT91919487 T AT 91919487T AT E132755 T1 ATE132755 T1 AT E132755T1
Authority
AT
Austria
Prior art keywords
uveitis
treatment
mycobacterium vaccae
vaccae
mycobacterium
Prior art date
Application number
AT91919487T
Other languages
English (en)
Inventor
Graham Arthur William Rook
Bumpstead
John Lawson Stanford
Original Assignee
Univ London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ London filed Critical Univ London
Application granted granted Critical
Publication of ATE132755T1 publication Critical patent/ATE132755T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Glass Compositions (AREA)
AT91919487T 1990-11-08 1991-11-08 Mycobacterium vaccae in der behandlung von uveitis ATE132755T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909024320A GB9024320D0 (en) 1990-11-08 1990-11-08 Treatment of uveitis

Publications (1)

Publication Number Publication Date
ATE132755T1 true ATE132755T1 (de) 1996-01-15

Family

ID=10685074

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91919487T ATE132755T1 (de) 1990-11-08 1991-11-08 Mycobacterium vaccae in der behandlung von uveitis

Country Status (10)

Country Link
EP (1) EP0556241B1 (de)
JP (1) JP3107568B2 (de)
AT (1) ATE132755T1 (de)
AU (1) AU665177B2 (de)
CA (1) CA2095854C (de)
DE (1) DE69116377T2 (de)
DK (1) DK0556241T3 (de)
GB (1) GB9024320D0 (de)
GR (1) GR3018652T3 (de)
WO (1) WO1992008484A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1038390C (zh) * 1993-03-20 1998-05-20 张锦铭 灭活卡介苗组合物
ES2171454T3 (es) 1993-06-04 2002-09-16 Whitehead Biomedical Inst Proteinas de estres y sus usos.
US5750119A (en) * 1994-01-13 1998-05-12 Mount Sinai School Of Medicine Of The City University Of New York Immunotherapeutic stress protein-peptide complexes against cancer
US5997873A (en) 1994-01-13 1999-12-07 Mount Sinai School Of Medicine Of The City University Of New York Method of preparation of heat shock protein 70-peptide complexes
US5961979A (en) * 1994-03-16 1999-10-05 Mount Sinai School Of Medicine Of The City University Of New York Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
US5935576A (en) 1995-09-13 1999-08-10 Fordham University Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
US5837251A (en) * 1995-09-13 1998-11-17 Fordham University Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
US5985270A (en) * 1995-09-13 1999-11-16 Fordham University Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes
US6406704B1 (en) 1996-08-29 2002-06-18 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6160093A (en) * 1996-08-29 2000-12-12 Genesis Researth And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6284255B1 (en) * 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US7157089B1 (en) 1996-11-26 2007-01-02 Stressgen Biotechnologies Corporation Immune responses using compositions containing stress proteins
US6017540A (en) 1997-02-07 2000-01-25 Fordham University Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
US5830464A (en) 1997-02-07 1998-11-03 Fordham University Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy
NZ538399A (en) 1997-08-05 2007-05-31 Nventa Biopharma Corp Fusion protein comprising an HPV E7 protein and a stress protein wherein the E7 protein is joined directly to the amino terminus of the stress protein
US5948646A (en) * 1997-12-11 1999-09-07 Fordham University Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes
US5968524A (en) * 1997-12-23 1999-10-19 Genesis Research & Development Corp. Methods and compounds for the treatment of immunologically-mediated psoriasis
US6328978B1 (en) 1997-12-23 2001-12-11 Genesis Research & Development Corp. Ltd. Methods for the treatment of immunologically-mediated skin disorders
WO1999042121A1 (en) 1998-02-20 1999-08-26 University Of Miami Modified heat shock protein-antigenic peptide complex
US6497880B1 (en) 1998-12-08 2002-12-24 Stressgen Biotechnologies Corporation Heat shock genes and proteins from Neisseria meningitidis, Candida glabrata and Aspergillus fumigatus
US6350457B1 (en) 1999-06-02 2002-02-26 Genesis Research & Development Corporation Limited Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
JP2003504074A (ja) 1999-07-08 2003-02-04 ストレスゲン バイオテクノロジーズ コーポレイション インビトロでのＴｈ１様応答の誘導
CA2396384A1 (en) 2000-01-14 2001-07-19 Whitehead Institute For Biomedical Research In vivo ctl elicitation by heat shock protein fusion proteins maps to a discrete atp binding domain and is cd4+ t cell-independent
EP1286693A4 (de) 2000-06-02 2005-07-13 Univ Connecticut Health Ct Komplexe aus alpha-2-makroglobulin und antigenen molekülen zur immuntherapie
NZ523408A (en) 2000-06-26 2006-02-24 Stressgen Biotechnologies Corp Human papilloma virus treatment
KR20030074787A (ko) 2001-02-05 2003-09-19 스트레스젠 바이오테크놀러지스 코포레이션 Ｂ형 간염 바이러스 치료
WO2003000721A2 (en) 2001-06-22 2003-01-03 Health Protection Agency Mycobacterial antigens expressed under low oxygen tension
JP2005508613A (ja) 2001-07-04 2005-04-07 ヘルス プロテクション エージェンシー 潜伏中に発現されるマイコバクテリア抗原
CN1635896A (zh) 2001-08-20 2005-07-06 康涅狄格大学健康中心 包含用于治疗癌症及感染性疾病的热休克蛋白或α2－巨球蛋白的组合物制备方法
US20060251739A1 (en) * 2005-05-04 2006-11-09 National Yang-Ming University Composition and method for treating autoimmune disease and mucosal disorder
DK2257301T3 (da) 2008-03-03 2014-04-28 Univ Miami Immunterapi baseret på allogene cancerceller.
JP2011515399A (ja) 2008-03-20 2011-05-19 ユニバーシティー オブ マイアミ 熱ショックタンパクｇｐ９６ワクチン接種及びそれを用いた方法
SG11201705844SA (en) 2015-02-06 2017-08-30 Heat Biologics Inc Vector co-expressing vaccine and costimulatory molecules
CA3040123A1 (en) 2016-10-11 2018-04-19 University Of Miami Vectors and vaccine cells for immunity against zika virus
CA3058938A1 (en) 2017-04-04 2018-10-11 Heat Biologics, Inc. Intratumoral vaccination

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8404280D0 (en) * 1984-02-17 1984-03-21 Stanford J L Biological preparations
IL71683A0 (en) * 1984-04-27 1984-09-30 Yeda Res & Dev Pharmaceutical compositions for treating arthritis type diseases comprising fractions obtained from mycobacteria
NL8701163A (nl) * 1986-09-09 1988-04-05 Nederlanden Staat Gebruik van een peptide voor de bereiding van preparaten voor het verlichten, het behandelen en de diagnose van autoimmuunziekten, in het bijzonder arthritische toestanden, verbindingen die met dit peptide verwant zijn, alsmede farmaceutische en diagnostische preparaten en testkits.
GB8917256D0 (en) * 1989-07-28 1989-09-13 Univ London Biological preparation and its use
GB8919321D0 (en) * 1989-08-25 1989-10-11 Univ London Treatment of chronic inflammatory conditions

Also Published As

Publication number Publication date
CA2095854A1 (en) 1992-05-09
AU8864491A (en) 1992-06-11
AU665177B2 (en) 1995-12-21
CA2095854C (en) 2003-08-19
DK0556241T3 (da) 1996-02-12
DE69116377D1 (de) 1996-02-22
EP0556241A1 (de) 1993-08-25
EP0556241B1 (de) 1996-01-10
GB9024320D0 (en) 1990-12-19
DE69116377T2 (de) 1996-05-30
JP3107568B2 (ja) 2000-11-13
JPH06501478A (ja) 1994-02-17
GR3018652T3 (en) 1996-04-30
WO1992008484A1 (en) 1992-05-29

Similar Documents

Publication Publication Date Title
ATE132755T1 (de) Mycobacterium vaccae in der behandlung von uveitis
ATE31670T1 (de) Verfahren zur behandlung von verpackungsmaterial und das dementsprechend behandelte material.
DE3483040D1 (de) Maschinelesbares dokument und dessen behandlung.
DE68909219D1 (de) Behandlung von obesitas.
IT8467672A1 (it) Composizione per capelli e procedimento di trattamento dei capelli.
DE69001458D1 (de) Mit einer benzotriazolgruppe substituierte diorganopolysiloxane enthaltende kosmetika sowie deren verwendung zum schutz von haut und haaren.
DE69113924D1 (de) Gravierverfahren von Gegenständen in fester Form und die hergestellten Gegenstände.
ATE151641T1 (de) Mycobacterium vaccae zur behandlung von langwierigen autoimmunerkrankungen
AP9600861A0 (en) Immunotherapeutic agent and its use.
ATE974T1 (de) Mittel und verfahren zur behandlung und verbesserung des aussehens von textilien.
FI870484A7 (fi) Tekstiilinkäsittelykoostumus ja -menetelmä.
JPS56100710A (en) Hair permanent treatment and composition therefor
RU93004600A (ru) Применение mycobacterium vaccae, способ лечения, продукт m vaccae, иммунотерапевтический агент
DE58901593D1 (de) Verfahren und einrichtung zur thermischen behandlung von abfallstoffen.
FI920356A0 (fi) En biologisk preparation samt dess anvaendning.
DE69127821D1 (de) Herstellung von siliciumnitrid mit verdichtungshilfsmittel, und resultate
DE69034166D1 (de) Azellulärer Impfstoff
DK161320C (da) Analogifremgangsmaade til fremstilling af 2,3-diaryl-5-halogen-thiophener
ATE139259T1 (de) Selbstantigen der primären lebercirrhose
DE59008012D1 (de) Mittel zur Behandlung von Leder und Pelzen.
ATE81455T1 (de) (s)-emopamil zur anwendung bei der behandlung von migraene.
DE69012298D1 (de) Heizen von Lagern und dergleichen.
DE3781032D1 (de) Warmbehandlung von lagermaterial.
IT1103459B (it) Dispositivo e procedimento per l'impianto di capelli
ATE53374T1 (de) Verfahren und mittel zur bekaempfung der kaffeeminiermotte, insbesondere der art perileucoptera coffeella.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee